Abstract
Abstract Reactivation of granulomatous diseases is a well-documented risk of biologic therapy. This case highlights a patient well controlled on chronic infliximab therapy, developing symptoms consistent with disease progression. The patient underwent a surgical laparoscopy given concern of small bowel obstruction in which diffuse, peritoneal nodularity was seen. Further staining revealed broad-budding yeast and blastomyces urinary antigen resulted as positive. The patient was treated for disseminated blastomycosis, and his symptoms completely resolved.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
